title: High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
abstract: The expression of cyclin-dependent kinase inhibitor p27(kip1) in human tumors and normal tissues was investigated using a panel of novel anti-p27(kip1) mAbs. An inverse correlation between expression of p27(kip1) and cell proliferation was generally observed after analyzing its expression in 25 different normal human tissues. In some highly proliferative human breast cancer cells, however, high level p27(kip1) expression was seen, indicating the existence of a mechanism by which some growing tumor cells may tolerate this inhibitor of cell cycle progression. Detailed studies demonstrated a correlation between the high level expression of p27(kip1) and cyclin D1 in human breast cancer cells. There was also an inverse correlation between the expression of p27(kip1) and the degree of tumor malignancy in human breast and colorectal cancers, indicating that p27(kip1) may be a useful prognostic marker in these cancers.
authors.affiliation: Ludwig Institute for Cancer Research, Imperial College School of Medicine at St. Mary's, Norfolk Place, London, W2 1PG, United Kingdom.
authors.forename: S
authors.initials: S
authors.lastname: Fredersdorf
authors.forename: J
authors.initials: J
authors.lastname: Burns
authors.forename: A M
authors.initials: AM
authors.lastname: Milne
authors.forename: G
authors.initials: G
authors.lastname: Packham
authors.forename: L
authors.initials: L
authors.lastname: Fallis
authors.forename: C E
authors.initials: CE
authors.lastname: Gillett
authors.forename: J A
authors.initials: JA
authors.lastname: Royds
authors.forename: D
authors.initials: D
authors.lastname: Peston
authors.forename: P A
authors.initials: PA
authors.lastname: Hall
authors.forename: A M
authors.initials: AM
authors.lastname: Hanby
authors.forename: D M
authors.initials: DM
authors.lastname: Barnes
authors.forename: S
authors.initials: S
authors.lastname: Shousha
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Hare
authors.forename: X
authors.initials: X
authors.lastname: Lu
mesh_terms: D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D002453:Cell Cycle; D018797:Cell Cycle Proteins; D002455:Cell Division; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D019938:Cyclin D1; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors; D016213:Cyclins / Q000032:analysis / Q000096:biosynthesis*; D005260:Female; D016147:Genes, Tumor Suppressor; D006801:Humans; D007150:Immunohistochemistry; D007700:Kinetics; D008297:Male; D008869:Microtubule-Associated Proteins / Q000032:analysis / Q000096:biosynthesis*; D015513:Oncogene Proteins / Q000032:analysis / Q000096:biosynthesis*; D009928:Organ Specificity; D011379:Prognosis; D012016:Reference Values; D014407:Tumor Cells, Cultured; D025521:Tumor Suppressor Proteins
chemical_list: D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D016213:Cyclins; D008869:Microtubule-Associated Proteins; D015513:Oncogene Proteins; D025521:Tumor Suppressor Proteins; D019938:Cyclin D1; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases